VERA FILES FACT CHECK: Vaccine czar DID NOT say jab with low efficacy is enough for the ‘poor’
There are no official records nor any report from news organizations of Galvez making such a remark.
There are no official records nor any report from news organizations of Galvez making such a remark.
Health experts and authorities say a direct link between the drug and ITP remains uncertain.
Responding to critics who said the Philippines is falling behind the coronavirus disease 2019 (COVID-19) vaccination drive in Asia, Palace Spokesperson Harry Roque mistakenly claimed that only three countries in the region have started their vaccination rollouts as of Feb. 2.
Sa kanyang mga social media account noong Peb. 1, mali ang datos na binanggit ni dating senador Antonio "Sonny" Trillanes IV tungkol sa coronavirus disease (COVID-19) vaccination program ng Israel.
In his social media accounts on Feb. 1, former senator Antonio “Sonny” Trillanes IV cited incorrect data on Israel’s coronavirus disease 2019 (COVID-19) vaccination program. His claim on the vaccination status of the member-states of the Association of Southeast Asian Nations (ASEAN) needs context.
President Rodrigo Duterte insinuated that the recent deaths of elderly persons in Norway were caused by the coronavirus disease 2019 (COVID-19) vaccine of Pfizer-BioNTech. This needs context.
Health experts said Skelton’s case is “likely a coincidence and not caused by the vaccine itself.”
Although there has been no conclusive data yet on the safety and efficacy of some candidate vaccines against the coronavirus disease 2019 (COVID-19), top government officials have already vouched for their effectiveness.
Sa hindi bababa sa tatlong magkakahiwalay na briefing, mali ang sinasabi ni Presidential Spokesperson Harry Roque na mga resulta ng interim clinical trial ng Indonesia sa CoronaVac, ang bakuna laban sa coronavirus disease 2019 (COVID-19) na dinebelop ng Chinese firm na Sinovac Biotech.
In at least three separate briefings, Presidential Spokesperson Harry Roque misstated the interim clinical trial results of Indonesia on CoronaVac, a vaccine against the coronavirus disease 2019 (COVID-19) developed by Chinese firm Sinovac BioTech.